These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 608659)

  • 1. Malignant neuroleptic syndrome--its present status in Japan and clinical problems.
    Itoh H; Ohtsuka N; Ogita K; Yagi G; Miura S; Koga Y
    Folia Psychiatr Neurol Jpn; 1977; 31(4):559-76. PubMed ID: 608659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Late irreversible extrapyramidal syndrome following neuroleptic use].
    Boucebci M
    Acta Psychiatr Belg; 1972 Mar; 72(2):233-40. PubMed ID: 5056017
    [No Abstract]   [Full Text] [Related]  

  • 3. A pilot investigation in neuroleptic therapy.
    Mattke DJ
    Dis Nerv Syst; 1968 Aug; 29(8):515-24. PubMed ID: 4877897
    [No Abstract]   [Full Text] [Related]  

  • 4. [Letter: Tardive dyskinesia, a little-known extrapyramidal syndrome due to therapy with neuroleptics].
    Berchtold P; Hinssen M; Irmscher K
    Dtsch Med Wochenschr; 1974 Mar; 99(9):420-1. PubMed ID: 4151333
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurologic syndromes associated with antipsychotic-drug use.
    N Engl J Med; 1973 Jul; 289(1):20-3. PubMed ID: 4708951
    [No Abstract]   [Full Text] [Related]  

  • 6. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
    Lee JW
    Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome.
    Weinberg S; Twersky RS
    Anesth Analg; 1983 Sep; 62(9):848-50. PubMed ID: 6136239
    [No Abstract]   [Full Text] [Related]  

  • 8. The extrapyramidal neuroleptic syndrome: description and measurement.
    Elie R; Gagnon MA; Lamontagne Y; Tetreault L
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):427-40. PubMed ID: 4198304
    [No Abstract]   [Full Text] [Related]  

  • 9. [Somatic disorders during long-term drug treatment of schizophrenic patients].
    vom Brocke I
    Internist (Berl); 1974 May; 15(5):268-70. PubMed ID: 4213663
    [No Abstract]   [Full Text] [Related]  

  • 10. The neuroleptic malignant syndrome.
    Kimsey LR; Gibbs JT; Glen RS; Markette JR; Kosted E
    Tex Med; 1983 Oct; 79(10):54-5. PubMed ID: 6138871
    [No Abstract]   [Full Text] [Related]  

  • 11. [Late extrapyramidal hyperkineses after prolonged neuroleptic therapy].
    Hippius H; Lange J
    Arzneimittelforschung; 1970 Jul; 20(7):888-90. PubMed ID: 5536050
    [No Abstract]   [Full Text] [Related]  

  • 12. [Malignant neuroleptic syndrome. Literature review and case report].
    Wäger O; Hell D
    Schweiz Med Wochenschr; 1988 Jan; 118(1):27-31. PubMed ID: 3278369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases.
    Goulon M; de Rohan-Chabot P; Elkharrat D; Gajdos P; Bismuth C; Conso F
    Neurology; 1983 Apr; 33(4):516-8. PubMed ID: 6682201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R; Gagnon MA; Gauthier R; Jéquier JC
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract]   [Full Text] [Related]  

  • 15. General anesthesia after neuroleptic malignant syndrome.
    Lotstra F; Linkowski P; Mendlewicz J
    Biol Psychiatry; 1983 Feb; 18(2):243-7. PubMed ID: 6131703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs].
    Ferrari P; Robotti E; Nardini M
    Boll Chim Farm; 1972 Oct; 111(10):610-5. PubMed ID: 4566407
    [No Abstract]   [Full Text] [Related]  

  • 17. [Extrapyramidal symptoms following Clozapine therapy. Case report].
    Doepp S; Buddeberg C
    Nervenarzt; 1975 Oct; 46(10):589-90. PubMed ID: 811999
    [No Abstract]   [Full Text] [Related]  

  • 18. Extrapyramidal syndromes complicating neuroleptic drug therapy.
    Bharucha EP
    J Assoc Physicians India; 1976 Jun; 24(6):383-5. PubMed ID: 1022771
    [No Abstract]   [Full Text] [Related]  

  • 19. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
    Huygens H; Vereecken JL; Tanghe A
    Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374
    [No Abstract]   [Full Text] [Related]  

  • 20. [Present-day possibilities of relieving post-neuroleptic extrapyramidal symptoms].
    Wasik A
    Psychiatr Pol; 1973; 7(1):51-6. PubMed ID: 4715833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.